NasdaqGS - Delayed Quote USD

Acumen Pharmaceuticals, Inc. (ABOS)

Compare
1.5700
-0.0300
(-1.87%)
At close: January 29 at 4:00:01 PM EST
1.5701
+0.00
+(0.01%)
After hours: January 29 at 5:45:09 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
310,125.0000
196,587.0000
230,330.0000
44,429.0000
Total Liabilities Net Minority Interest
43,152.0000
7,812.0000
5,147.0000
63,020.0000
Total Equity Gross Minority Interest
266,973.0000
188,775.0000
225,183.0000
-18,591.0000
Total Capitalization
294,310.0000
188,775.0000
225,183.0000
-18,591.0000
Common Stock Equity
266,973.0000
188,775.0000
225,183.0000
-18,591.0000
Capital Lease Obligations
1,150.0000
105.0000
--
--
Net Tangible Assets
266,973.0000
188,775.0000
225,183.0000
-18,591.0000
Working Capital
233,644.0000
172,517.0000
193,514.0000
38,062.0000
Invested Capital
294,310.0000
188,775.0000
225,183.0000
-18,591.0000
Tangible Book Value
266,973.0000
188,775.0000
225,183.0000
-18,591.0000
Total Debt
28,487.0000
105.0000
--
--
Share Issued
57,910.4610
41,025.0620
40,473.2700
38,651.7950
Ordinary Shares Number
57,910.4610
41,025.0620
40,473.2700
38,651.7950
12/31/2020 - 7/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers